$STX

Romano Gianluca sold $5.7M of STX

Romano Gianluca (EVP & CFO) sold 7,240 shares of Seagate Technology Holdings plc (STX) at an average of $781.64 ($763.39–$798.33, $5.66M total) across 29 trades on 2026-08-07 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Romano Gianluca
Published Aug 11, 2026, 8:21 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$STX
Neutral
medium confidence
Mentioned
$STX
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$STXNeutralLow
01

Why it matters

The newest disclosed fact is the CFO’s $5.66M open-market sale of 7,240 shares on 2026-08-07, reported via a 10b5-1 plan.

02

Market read

This provides a fresh, primary-source datapoint on insider selling, but the 10b5-1 structure makes it less likely to drive a fundamental repricing.

03

What to watch

The filing does not disclose reasons for the sale, and the price range ($763.39 to $798.33) suggests execution across multiple trades rather than a single timing bet.

Relevance 5/10Novelty 3/10Timing: SEC Form 4 filed 2026-08-11, covering sales executed 2026-08-07

Background

The article is an SEC Form 4 insider transaction disclosure for Seagate Technology Holdings plc (STX).

Company-level read

Ticker impact

$STXNeutralMedium confidence
Context

Seagate CFO Romano Gianluca sold about 7,240 shares in an open-market transaction totaling $5.66M, under a 10b5-1 plan filed on SEC EDGAR.

Expected impact

Likely limited immediate price impact; any effect is more about sentiment than fundamentals.

Evidence & confidence

The filing is a primary-source Form 4, but the transaction is coded as an open-market sale executed under a pre-arranged 10b5-1 plan, which typically dampens interpretive value versus discretionary selling.

Market effects

No direct sector read-through; this is company-specific insider activity without operational or guidance changes.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect routine liquidity planning rather than bearish expectations, so traders may overreact if they treat it as discretionary.

Key entities

  • Seagate Technology Holdings plc

    Subject of the Form 4 insider transaction disclosure.

  • Romano Gianluca

    EVP and CFO who sold shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVDAHighAI 9/10

Markets News, Aug. 27, 2026: Nvidia Stock Powers Higher After Earnings, Driving Tech Gains; Nasdaq Closes Sharply Higher

Nvidia (NVDA) reported strong Q2 earnings and raised Q3 revenue guidance to $108B, driving its stock up 9% and boosting tech sector gains. Nasdaq, S&P 500, and Dow closed higher. Other notable movers include Okta (OKTA) +29%, Salesforce (CRM) +23%, and CrowdStrike (CRWD) +20%. Corporate profits surged $400B in Q2, partly due to $71B in tariff refunds.

$STXMed

Moody’s upgrades Seagate Data rating on AI demand strength

Moody's upgraded Seagate Data's corporate family rating to Ba1 from Ba2, citing AI-driven demand for high-capacity HDDs. The agency expects revenues to grow over 30% annually, reaching $20B, and debt to EBITDA to fall below 0.5x. Seagate faces risks from revenue concentration and pricing pressures. The company had $1.7B in cash and access to a $1.3B credit facility as of July 2026.

$MRNAHighAI 8/10

3 Stocks Soared, 3 Stocks Slumped

Moderna (MRNA) surged 176.97% to $174.38 after reporting positive trial results for a cancer therapy with Merck (MRK). Estee Lauder (EL) rose 16% to $98.01 with revenue up 6.5% Y/Y. MicroStrategy (MSTR) gained 12.68% as Bitcoin prices rose. Nebius (NBIS) fell 10% after a $4.5B convertible note offering. Seagate (STX) dropped 8% to $832.56.

$STXMed

REG - Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US

Shield Therapeutics (STX) will take full control of ACCRUFeR® in the US from Viatris by September 30, 2026. The deal is expected to boost Shield's profitability and growth, with no upfront payments to Viatris. Shield will pay royalties on US net sales, ranging from high single digits to mid-teens over five years, and retain all gross profits from US sales. The transaction is anticipated to enhance Shield's financial profile and support its path to sustained profitability.